Drug:
Reaction: OVERDOSE
20250101 - 20251231
No. 2901 - 3000
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 2901 | 25216760 |
US |
23 | 1 |
Shock, Lactic acidosis, Acute kidney injury, Vomiting, Overdose, Nausea, Hyperglycaemia, Atrioventricular block second degree, |
||||
| 2902 | 25216978 |
US |
23 | 2 |
Acute hepatic failure, Encephalopathy, Brain oedema, Mental status changes, Overdose, Toxicity to various agents, Exposure during pregnancy, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2903 | 25217216 |
US |
1 | |
Wrong technique in product usage process, Overdose, Product prescribing error, |
||||
SAPROPTERIN DIHYDROCHLORIDE, |
||||
| 2904 | 25211830 |
NL |
23 | 1 |
Substance abuse, Coma, Depressed level of consciousness, Dyspnoea, Shock, Acute kidney injury, Hyperkalaemia, Hypertransaminasaemia, Rhabdomyolysis, Hyperlactacidaemia, Overdose, |
||||
OXYCODONE, OXYCODONE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 2905 | 25211837 |
US |
60 | 1 |
Overdose, Suicide attempt, Pyrexia, Tachycardia, Myoclonus, Serotonin syndrome, Respiratory distress, Pain, Flatulence, Intestinal pseudo-obstruction, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 2906 | 25211851 |
US |
50 | 2 |
Overdose, Hypotension, Hypoxia, Tachycardia, Intentional overdose, |
||||
CLONIDINE, CLONIDINE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, GABAPENTIN, GABAPENTIN, METHOCARBAMOL, METHOCARBAMOL TABLETS, METHOCARBAMOL, METHOCARBAMOL TABLETS, OLANZAPINE, OLANZAPINE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, |
||||
| 2907 | 25212698 |
US |
1 | |
Wrong technique in device usage process, Incorrect dose administered by device, Product dose omission issue, Eye disorder, Overdose, Device delivery system issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 2908 | 25212866 |
US |
40 | 2 |
Platelet count decreased, Overdose, |
||||
LACOSAMIDE, |
||||
| 2909 | 25212969 |
CA |
||
Cardio-respiratory arrest, Multiple fractures, Arteriosclerosis coronary artery, Toxicity to various agents, Toxicity to various agents, Drug abuse, Overdose, |
||||
PREGABALIN, NAPROXEN, NAPROXEN SODIUM, METHYLPHENIDATE HYDROCHLORIDE, OXAZEPAM, TEMAZEPAM, CLONAZEPAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), OXYCODONE, |
||||
| 2910 | 25212981 |
CN |
23 | 2 |
Asthenia, Haematemesis, Dizziness, Overdose, |
||||
SERTRALINE HYDROCHLORIDE, |
||||
| 2911 | 25213026 |
EU |
||
Poisoning, Cardiogenic shock, Pulmonary oedema, Suicide attempt, Overdose, Drug interaction, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, RIFAMPIN, ITRACONAZOLE, |
||||
| 2912 | 25213797 |
US |
||
Drug ineffective, Off label use, Overdose, Product preparation issue, |
||||
INCOBOTULINUMTOXINA, INCOBOTULINUMTOXINA, INCOBOTULINUMTOXINA, INCOBOTULINUMTOXINA, ONABOTULINUMTOXINA, |
||||
| 2913 | 25214252 |
GB |
2 | |
Renal failure, Overdose, Intentional product misuse, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 2914 | 25214287 |
CN |
16 | 2 |
Shock, Coma, Respiratory muscle weakness, Toxicity to various agents, Overdose, Bezoar, Hypotension, Epilepsy, Tachycardia, Off label use, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VALPROATE SODIUM, VALPROATE SODIUM, VALPROATE SODIUM, VALPROATE SODIUM, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 2915 | 25214879 |
US |
10 | 2 |
Overdose, Drug dose omission by device, Incorrect dose administered by device, Device use error, Device defective, Device delivery system issue, Device occlusion, |
||||
SOMATROPIN, SOMATROPIN, LEVOTHYROXINE, |
||||
| 2916 | 25215065 |
US |
23 | 2 |
Hypotension, Vasodilatation, Pulmonary oedema, Overdose, Suicide attempt, |
||||
AMLODIPINE, |
||||
| 2917 | 25215155 |
JP |
47 | 1 |
Toxicity to various agents, Altered state of consciousness, Overdose, Intentional product misuse, |
||||
IVERMECTIN, |
||||
| 2918 | 25215260 |
CO |
21 | 1 |
Malaise, Overdose, Hypertension, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, SERTRALINE, |
||||
| 2919 | 25215393 |
US |
33 | 2 |
Heart rate increased, Hepatic failure, Overdose, Muscle spasms, Blood pressure increased, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VOCLOSPORIN, |
||||
| 2920 | 25215667 |
BR |
2 | |
Malaise, Overdose, Prescription drug used without a prescription, |
||||
METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 2921 | 25215993 |
US |
2 | |
Pulmonary oedema, Product dose omission issue, Overdose, Incorrect dose administered, Respiration abnormal, Wrong technique in device usage process, Asthma, |
||||
GLYCOPYRROLATE AND FORMOTEROL FUMARATE, |
||||
| 2922 | 25216271 |
ES |
1 | |
Non-cardiogenic pulmonary oedema, Drug interaction, Toxicity to various agents, Overdose, Intentional product misuse, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), CLONAZEPAM, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, PROPOFOL, ALPRAZOLAM, ZOLPIDEM TARTRATE, FENTANYL, |
||||
| 2923 | 25216475 |
US |
63 | 2 |
Death, Fall, Hip fracture, Bronchitis, Back pain, Overdose, |
||||
AMLODIPINE, CARVEDILOL, DEXLANSOPRAZOLE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, ERYTHROMYCIN, FOLIC ACID, ISOSORBIDE MONONITRATE, LISINOPRIL, METAXALONE, MONTELUKAST, SODIUM CHLORIDE, OFLOXACIN, OFLOXACIN OTIC, OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3%, OFLOXACIN OTIC SOLUTION, POLYVINYL ALCOHOL, POVIDONE, LATANOPROST, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NIFEDIPINE, ROSUVASTATIN, PREGABALIN, METHOTREXATE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ADALIMUMAB, |
||||
| 2924 | 25205479 |
US |
23 | 2 |
Brain oedema, Exposure during pregnancy, Acute hepatic failure, Blood creatine increased, Metabolic function test abnormal, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2925 | 25205520 |
IN |
3 | |
Toxicity to various agents, Overdose, Cardiac contractility decreased, |
||||
ATENOLOL, AMLODIPINE, |
||||
| 2926 | 25205550 |
IT |
60 | 2 |
Pneumonitis, Overdose, Stupor, Hypotension, Alanine aminotransferase increased, |
||||
PHENOBARBITAL, |
||||
| 2927 | 25205753 |
NL |
23 | 1 |
Substance abuse, Food interaction, Drug interaction, Overdose, Coma, Shock, Cerebellar infarction, Toxic leukoencephalopathy, Acute kidney injury, Hyperkalaemia, Hypertransaminasaemia, Rhabdomyolysis, Hyperlactacidaemia, Hepatic failure, Hypotension, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, OXYCODONE, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 2928 | 25205908 |
HK |
||
Overdose, Shock, Lactic acidosis, |
||||
AMLODIPINE, |
||||
| 2929 | 25206093 |
GB |
62 | 1 |
Overdose, Metabolic acidosis, Hyperlactacidaemia, Hypotension, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 2930 | 25206139 |
ES |
2 | |
Drug dependence, Toxicity to various agents, Overdose, |
||||
| 2931 | 25206245 |
US |
1 | |
Incorrect dose administered, Overdose, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 2932 | 25206293 |
ES |
1 | |
Non-cardiogenic pulmonary oedema, Drug interaction, Toxicity to various agents, Overdose, Intentional product misuse, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, CLONAZEPAM, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, PROPOFOL, ALPRAZOLAM, ZOLPIDEM TARTRATE, FENTANYL, |
||||
| 2933 | 25206304 |
US |
6 | 1 |
Propofol infusion syndrome, Ventricular tachycardia, Partial seizures, Status epilepticus, Cerebral haemorrhage, Toxic leukoencephalopathy, Overdose, Incorrect product administration duration, |
||||
PROPOFOL, |
||||
| 2934 | 25206421 |
CA |
36 | 2 |
Contraindicated product administered, Drug ineffective, Drug intolerance, Intentional product misuse, Joint swelling, Off label use, Overdose, Pain, Prescribed overdose, Product use issue, Psoriasis, Pyrexia, Rash, Rash erythematous, Temperature regulation disorder, Thrombocytopenia, Treatment failure, Upper respiratory tract infection, Rheumatoid arthritis, Infection, |
||||
RITUXIMAB, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, PREGABALIN, TOFACITINIB, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 2935 | 25206533 |
FR |
||
Dysphagia, Somnolence, Overdose, Product prescribing error, Wrong dose, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 2936 | 25206657 |
NL |
23 | 1 |
Acute kidney injury, Hyperkalaemia, Rhabdomyolysis, Hyperlactacidaemia, Toxic leukoencephalopathy, Shock, Coma, Cerebellar infarction, Brainstem compression, Brain herniation, Renal failure, Substance abuse, Hepatic failure, Hypertransaminasaemia, Food interaction, Drug interaction, Overdose, Multiple organ dysfunction syndrome, Depressed level of consciousness, Unresponsive to stimuli, Hypoxia, Miosis, Respiration abnormal, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, OXYCODONE, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 2937 | 25206927 |
IT |
||
International normalised ratio increased, Agitation, Acute kidney injury, Abdominal pain upper, Drug interaction, Drug abuse, Overdose, Medication error, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, WARFARIN, |
||||
| 2938 | 25207075 |
JP |
3 | 1 |
Shock, Altered state of consciousness, Overdose, |
||||
AMLODIPINE BESYLATE, AZILSARTAN KAMEDOXOMIL, |
||||
| 2939 | 25207149 |
US |
23 | 2 |
Pulmonary oedema, Suicide attempt, Hypotension, Vasodilatation, Overdose, |
||||
AMLODIPINE, |
||||
| 2940 | 25207193 |
IT |
51 | 2 |
Metabolic acidosis, Anaemia, Thrombocytopenia, Pleural effusion, Gallbladder oedema, Hepatic necrosis, Renal cortical necrosis, Toxicity to various agents, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2941 | 25207492 |
CN |
16 | 2 |
Shock, Coma, Overdose, |
||||
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VALPROATE SODIUM, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 2942 | 25207645 |
US |
27 | 2 |
Overdose, Cardiogenic shock, Toxicity to various agents, |
||||
BUPROPION, |
||||
| 2943 | 25207755 |
51 | 2 | |
Hepatic necrosis, Renal cortical necrosis, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2944 | 25207931 |
DE |
23 | 2 |
Overdose, Suicide attempt, Conversion disorder, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, CLINDAMYCIN HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 2945 | 25207957 |
CN |
75 | 1 |
Unresponsive to stimuli, Dysphonia, Listless, Loss of consciousness, Asthenia, Somnolence, Overdose, |
||||
ZOLPIDEM TARTRATE, |
||||
| 2946 | 25207994 |
US |
2 | |
Product dose omission issue, Overdose, Relapsing multiple sclerosis, Illness, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, |
||||
| 2947 | 25208008 |
US |
36 | 2 |
Brain oedema, Overdose, Hypotension, Cardiotoxicity, Electrocardiogram QRS complex prolonged, Tachycardia, Seizure, Toxicity to various agents, Pulseless electrical activity, |
||||
HYDROXYCHLOROQUINE SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 2948 | 25208024 |
CN |
52 | 2 |
Toxicity to various agents, Overdose, Intentional product misuse, Constipation, Anxiety, Abulia, Psychomotor retardation, Salivary hypersecretion, Anosognosia, Memory impairment, Jealous delusion, Delusion of reference, Distractibility, |
||||
RISPERIDONE, ZIPRASIDONE, CRATAEGUS, HAWTHORN LEAF WITH FLOWER, PROPRANOLOL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE, CLOZAPINE, OLANZAPINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 2949 | 25208056 |
CN |
54 | 1 |
Drug-induced liver injury, Diarrhoea, Overdose, |
||||
| 2950 | 25208639 |
BR |
79 | 1 |
Dyspnoea, Multiple use of single-use product, Medication error, Overdose, Respiratory disorder, Lung disorder, Discomfort, Fatigue, Condition aggravated, Viral infection, |
||||
LOSARTAN, DAPAGLIFLOZIN, |
||||
| 2951 | 25208941 |
AT |
46 | 1 |
Cardio-respiratory arrest, Rhabdomyolysis, Lactic acidosis, Overdose, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, RAMIPRIL, |
||||
| 2952 | 25209924 |
US |
76 | 2 |
Rheumatoid arthritis, Dry skin, Skin exfoliation, Pruritus, Dizziness, Stress, Oral herpes, Overdose, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIPHENHYDRAMINE HYDROCHLORIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, FOLIC ACID, FUROSEMIDE, GLIMEPIRIDE, METOPROLOL TARTRATE, METOPROLOL, PREDNISONE, INSULIN DEGLUDEC, LINACLOTIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, LOVASTATIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE, LOSARTAN POTASSIUM, LOSARTAN, TIZANIDINE, PANTOPRAZOLE, LORATADINE, LORATADINE ORAL, HYDROCHLOROTHIAZIDE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 2953 | 25209982 |
CA |
40 | 2 |
C-reactive protein increased, Incorrect product administration duration, Overdose, Underdose, Epilepsy, Asthenia, Depression, Facet joint syndrome, Blister, Duodenal ulcer perforation, Fibromyalgia, Coeliac disease, Blepharospasm, Breast cancer stage III, Dizziness, Abdominal pain upper, Dry mouth, Diarrhoea, Rheumatoid arthritis, Contraindicated product administered, C-reactive protein abnormal, Drug ineffective, Condition aggravated, Intentional product use issue, Onychomycosis, Product use in unapproved indication, Product use issue, Therapeutic product effect decreased, Therapeutic product effect incomplete, Treatment failure, Confusional state, Drug hypersensitivity, Drug intolerance, Drug-induced liver injury, Dyspepsia, Dyspnoea, Exposure during pregnancy, Abdominal discomfort, Fatigue, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Abdominal distension, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Adverse reaction, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Alopecia, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Anti-cyclic citrullinated peptide antibody positive, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Off label use, Arthralgia, Onychomadesis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Arthropathy, Product label confusion, Product quality issue, Psoriatic arthropathy, Rash, Rheumatic fever, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Blood cholesterol increased, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Bursitis, Fall, |
||||
TRAMADOL HYDROCHLORIDE, LEFLUNOMIDE, METHYLPREDNISOLONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TETRACYCLINE HYDROCHLORIDE, TOCILIZUMAB, TOFACITINIB, RITUXIMAB-ABBS, PREDNISONE, APREMILAST, LEFLUNOMIDE, ATOMOXETINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CELECOXIB, CERTOLIZUMAB PEGOL, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOGESTREL AND ETHINYL ESTRADIOL, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN AND CODEINE, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, ALENDRONATE SODIUM, GOLD, TOCILIZUMAB, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LAMOTRIGINE, LEFLUNOMIDE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE ACETATE, MINOCYCLINE, MINOCYCLINE HYDROCHLORIDE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, ERENUMAB-AOOE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, ABATACEPT, APREMILAST, OXYCODONE, PHENYLEPHRINE HYDROCHLORIDE, ALENDRONATE SODIUM, PREDNISONE, RAMIPRIL, RANITIDINE, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, RITUXIMAB, SULFASALAZINE, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, THIAMINE HYDROCHLORIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VITAMIN A, TOFACITINIB, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, USTEKINUMAB, AZATHIOPRINE SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, HYDROXYCHLOROQUINE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 2954 | 25209989 |
CN |
||
Hallucination, visual, Abdominal pain, Vision blurred, Toxicity to various agents, Overdose, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, OXAZEPAM, FLUOXETINE HYDROCHLORIDE, |
||||
| 2955 | 25210118 |
AU |
14 | 2 |
Hypopituitarism foetal, Overdose, Device delivery system issue, Off label use, |
||||
SOMATROPIN, |
||||
| 2956 | 25210135 |
FR |
||
Encephalopathy, Pancytopenia, Drug interaction, Overdose, |
||||
LAMOTRIGINE, CANNABIDIOL, VALPROATE SODIUM, CLOBAZAM, |
||||
| 2957 | 25210425 |
GB |
30 | 2 |
Overdose, |
||||
| 2958 | 25210714 |
US |
1 | |
Overdose, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 2959 | 25210767 |
AT |
46 | 1 |
Rhabdomyolysis, Cardio-respiratory arrest, Lactic acidosis, Overdose, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, RAMIPRIL, |
||||
| 2960 | 25210777 |
ES |
1 | |
Non-cardiogenic pulmonary oedema, Drug interaction, Intentional product misuse, Overdose, Toxicity to various agents, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), ZOLPIDEM TARTRATE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, FENTANYL, ALPRAZOLAM, CLONAZEPAM, PROPOFOL, |
||||
| 2961 | 25214726 |
32 | 2 | |
Suicidal ideation, Suicide attempt, Thermal burn, Intentional self-injury, Overdose, |
||||
MONTELUKAST SODIUM, MONTELUKAST, OXYCODONE, SERTRALINE, |
||||
| 2962 | 25201343 |
US |
||
Overdose, |
||||
FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE CHEWABLE TABLET, FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE, |
||||
| 2963 | 25201452 |
FR |
17 | 2 |
Abdominal pain, Vomiting, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2964 | 25201536 |
ES |
||
Bone marrow failure, Septic shock, Abscess, Overdose, |
||||
RITUXIMAB, RITUXIMAB, ETOPOSIDE, ETOPOSIDE, CARBOPLATIN, CARBOPLATIN, CISPLATIN, CISPLATIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, |
||||
| 2965 | 25202030 |
DE |
23 | 2 |
Suicide attempt, Overdose, Conversion disorder, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, MINOCYCLINE, CLINDAMYCIN HYDROCHLORIDE, |
||||
| 2966 | 25202278 |
US |
50 | 2 |
Distributive shock, Overdose, |
||||
BUPROPION, CLONIDINE, GABAPENTIN, CYCLOBENZAPRINE, METHOCARBAMOL, METHOCARBAMOL TABLETS, DULOXETINE HYDROCHLORIDE, DULOXETINE, MAGNESIUM OXIDE, OLANZAPINE, |
||||
| 2967 | 25202617 |
US |
39 | 1 |
Overdose, Distributive shock, Acute kidney injury, Drug ineffective, |
||||
AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, PROMETHAZINE, PROMETHAZINE, PROMETHAZINE, PROMETHAZINE, EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, CYCLOBENZAPRINE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, VASOPRESSIN, VASOPRESSIN, VASOPRESSIN, VASOPRESSIN, ANGIOTENSIN II, ANGIOTENSIN II, ANGIOTENSIN II, ANGIOTENSIN II, |
||||
| 2968 | 25202621 |
US |
23 | 2 |
Overdose, Brain oedema, Acute hepatic failure, Toxicity to various agents, Maternal exposure during pregnancy, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2969 | 25202719 |
GB |
59 | 1 |
Alopecia, Affective disorder, Rhinalgia, Platelet count decreased, Neutrophil count decreased, Fatigue, Overdose, Cellulitis, Neuropathy peripheral, Extrapyramidal disorder, COVID-19, Intentional product misuse, Lymphocyte count abnormal, Lymphocyte count abnormal, Dyspepsia, Off label use, Off label use, Off label use, Diarrhoea, Schizophrenia, Thrombocytopenia, Leukocytosis, Incorrect dose administered, Fatigue, Fatigue, Leukopenia, Lymphocyte count decreased, Nausea, Neutrophil count increased, Delusion of grandeur, Hospitalisation, Disease progression, Leukocytosis, Mucosal inflammation, Neoplasm progression, Psychotic disorder, Hallucination, auditory, Seizure, Neutropenia, Extrapyramidal disorder, SARS-CoV-2 test positive, Leukocytosis, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, MIRTAZAPINE, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, CHLORPROMAZINE, CHLORPROMAZINE, CHLORPROMAZINE, CHLORPROMAZINE, CHLORPROMAZINE, CHLORPROMAZINE, CHLORPROMAZINE, CHLORPROMAZINE, CHLORPROMAZINE, CHLORPROMAZINE, CHLORPROMAZINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, DENOSUMAB, MORPHINE SULFATE, MORPHINE SULFATE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, MORPHINE, MORPHINE, MORPHINE, MORPHINE, MORPHINE, MORPHINE, MORPHINE, |
||||
| 2970 | 25202840 |
FR |
||
Depression, Psychotic disorder, Personality disorder, Overdose, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB, |
||||
| 2971 | 25203062 |
US |
72 | 2 |
Aspiration joint, Dehydration, Blood disorder, Osteoporosis, Abdominal pain, Alopecia, Glossodynia, Dysphonia, Arthralgia, Headache, Musculoskeletal chest pain, Crepitations, Constipation, Arthralgia, Gastrointestinal disorder, Skin striae, Rash macular, Skin hypopigmentation, Skin atrophy, Neuralgia, Muscle atrophy, Hypoaesthesia, Overdose, Recalled product administered, Wrong technique in product usage process, Off label use, Drug ineffective for unapproved indication, |
||||
METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, HYDROCORTISONE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 2972 | 25203141 |
PL |
48 | 1 |
Somnolence, Toxicity to various agents, Suicide attempt, Overdose, |
||||
ZOLPIDEM TARTRATE, |
||||
| 2973 | 25203172 |
FR |
47 | 1 |
Agitation, Somnolence, Substance use disorder, Altered state of consciousness, Rectocele, Dysarthria, Overdose, |
||||
FENTANYL, FENTANYL, GABAPENTIN, METHADONE HYDROCHLORIDE, METHADONE, PANTOPRAZOLE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, |
||||
| 2974 | 25203232 |
US |
27 | 2 |
Pulmonary oedema, Cardiogenic shock, Ventricular tachycardia, Toxicity to various agents, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2975 | 25203887 |
CN |
52 | 2 |
Toxicity to various agents, Distractibility, Delusion of reference, Jealous delusion, Memory impairment, Anosognosia, Salivary hypersecretion, Psychomotor retardation, Abulia, Anxiety, Constipation, Intentional product misuse, Overdose, |
||||
ZIPRASIDONE MESYLATE, RISPERIDONE, RISPERIDONE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, OLANZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 2976 | 25203990 |
CA |
36 | 2 |
Contraindicated product administered, Drug ineffective, Drug intolerance, Intentional product misuse, Joint swelling, Off label use, Overdose, Pain, Prescribed overdose, Product use issue, Psoriasis, Pyrexia, Rash, Rash erythematous, Rheumatoid arthritis, Temperature regulation disorder, Thrombocytopenia, Treatment failure, Upper respiratory tract infection, |
||||
HYDROMORPHONE HYDROCHLORIDE, MORPHINE SULFATE, MORPHINE SULFATE, ABACAVIR SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN AND CODEINE, ALBUTEROL SULFATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE, PROGESTERONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DOLUTEGRAVIR SODIUM, LAMIVUDINE, LAMIVUDINE ORAL, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, NORTRIPTYLINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PROGESTERONE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, CLONIDINE HYDROCHLORIDE, CLONIDINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, ONDANSETRON HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 2977 | 25204100 |
US |
26 | 2 |
Overdose, |
||||
MORPHINE SULFATE, |
||||
| 2978 | 25204328 |
CA |
63 | 1 |
Death, Overdose, |
||||
SUCROFERRIC OXYHYDROXIDE, |
||||
| 2979 | 25204601 |
US |
26 | 1 |
Overdose, Impaired driving ability, Road traffic accident, Drug screen positive, Tachycardia, |
||||
FENTANYL, ALPRAZOLAM, |
||||
| 2980 | 25195997 |
US |
||
Toxicity to various agents, Overdose, Brain oedema, Encephalopathy, Acute hepatic failure, Maternal exposure during pregnancy, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2981 | 25195999 |
JP |
||
Ventricular tachycardia, Generalised tonic-clonic seizure, Altered state of consciousness, Respiratory acidosis, Toxicity to various agents, Dyspnoea, Overdose, |
||||
LAMOTRIGINE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, |
||||
| 2982 | 25196086 |
NL |
||
Toxic leukoencephalopathy, Acute kidney injury, Hyperkalaemia, Rhabdomyolysis, Shock, Coma, Cerebellar infarction, Brainstem compression, Brain herniation, Renal failure, Hepatic failure, Substance abuse, Hypertransaminasaemia, Hyperlactacidaemia, Drug interaction, Food interaction, Overdose, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, OXYCODONE, |
||||
| 2983 | 25196120 |
US |
60 | 1 |
Intestinal pseudo-obstruction, Suicide attempt, Myoclonus, Overdose, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 2984 | 25196139 |
US |
47 | 1 |
Inappropriate schedule of product administration, Overdose, |
||||
IXEKIZUMAB, IXEKIZUMAB, |
||||
| 2985 | 25196349 |
US |
46 | 2 |
Inappropriate schedule of product administration, Overdose, Injection site bruising, Injection site erythema, Injection site induration, Injection site pain, |
||||
IXEKIZUMAB, IXEKIZUMAB, IXEKIZUMAB, |
||||
| 2986 | 25196525 |
US |
54 | 2 |
Overdose, Off label use, Atrial fibrillation, Drug ineffective, |
||||
NALOXONE, |
||||
| 2987 | 25196616 |
CA |
||
Foot fracture, Overdose, |
||||
| 2988 | 25196949 |
US |
24 | 2 |
Hypothermia, Hypoglycaemia, Confusional state, Overdose, Intentional product misuse, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 2989 | 25197004 |
US |
32 | 2 |
Mental status changes, Hypoglycaemia, Intentional product misuse, Overdose, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 2990 | 25197031 |
US |
14 | 2 |
Hypothermia, Hypoglycaemia, Abdominal pain, Nausea, Vomiting, Overdose, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, PHENTERMINE HYDROCHLORIDE, |
||||
| 2991 | 25197070 |
US |
32 | 2 |
Cardiogenic shock, Unresponsive to stimuli, Ventricular tachycardia, Multiple organ dysfunction syndrome, Toxicity to various agents, Cardiac arrest, Respiratory failure, Overdose, |
||||
BUPROPION HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 2992 | 25197411 |
US |
21 | 2 |
Hypothermia, Abdominal pain, Agitation, Hypoglycaemia, Intentional product misuse, Overdose, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 2993 | 25197843 |
GB |
1 | |
Schizophrenia, Suicide attempt, Overdose, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, |
||||
| 2994 | 25197861 |
US |
96 | 2 |
Cardiac arrest, Overdose, |
||||
ZOLPIDEM TARTRATE, CALCIUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ESZOPICLONE, LORAZEPAM, MELATONIN, METHOCARBAMOL, METHOCARBAMOL TABLETS, RAMELTEON, TEMAZEPAM, DIAZEPAM, ZALEPLON, |
||||
| 2995 | 25198227 |
NL |
23 | 1 |
Acute kidney injury, Hyperkalaemia, Hypertransaminasaemia, Rhabdomyolysis, Hyperlactacidaemia, Toxic leukoencephalopathy, Shock, Coma, Cerebellar infarction, Brainstem compression, Brain herniation, Substance abuse, Renal failure, Hepatic failure, Food interaction, Drug interaction, Overdose, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, OXYCODONE, |
||||
| 2996 | 25198763 |
FR |
74 | 1 |
Respiratory syncytial virus infection, Drug interaction, Overdose, |
||||
CEFTAZIDIME, BISOPROLOL FUMARATE, RAMIPRIL, FUROSEMIDE, FUROSEMIDE, APIXABAN, PANTOPRAZOLE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 2997 | 25198955 |
US |
56 | 1 |
Overdose, Influenza, Dizziness, |
||||
NALTREXONE, NALTREXONE, DULOXETINE HYDROCHLORIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, AMLODIPINE, ROSUVASTATIN, |
||||
| 2998 | 25199062 |
NL |
23 | 1 |
Acute kidney injury, Hyperkalaemia, Rhabdomyolysis, Toxic leukoencephalopathy, Shock, Coma, Cerebellar infarction, Brainstem compression, Brain herniation, Renal failure, Hepatic failure, Hypertransaminasaemia, Hyperlactacidaemia, Hypotension, Food interaction, Drug interaction, Substance abuse, Overdose, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 2999 | 25199194 |
51 | 2 | |
Overdose, Muscle spasms, Vomiting, Substance use, |
||||
| 3000 | 25199574 |
US |
20 | 2 |
Multiple organ dysfunction syndrome, Overdose, Hypotension, Somnolence, Generalised oedema, Toxicity to various agents, Vasoplegia syndrome, Cardiac arrest, Hypoxia, Cardiac failure high output, Pulmonary oedema, Renal failure, |
||||
AMLODIPINE BESYLATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30
